REGENERON PHARMACEUTICALS INC financial statements, including revenue, expenses, profit, and loss

The total revenue of REGN for the last quarter is 73.31 B MXN, and it's 12.68% higher compared to the previous quarter. The net income of Q3 24 is 26.41 B MXN.